Zomedica Capital Expenditures (CapEx) Growth & History (ZOMDF)
Zomedica's capital expenditures (capex) was $567,000 for fiscal 2025.
View full Zomedica company overviewZomedica annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $567,000 | −$4.6M | −89.12% |
| 2024 | 2024-12-31 | $5.2M | −$6.1M | −54.03% |
| 2023 | 2023-12-31 | $11.3M | $10.6M | +1340.79% |
| 2022 | 2022-12-31 | $787,000 | $640,000 | +435.37% |
| 2021 | 2021-12-31 | $147,000 | $132,150 | +889.90% |
| 2020 | 2020-12-31 | $14,850 | −$140,663 | −90.45% |
| 2019 | 2019-12-31 | $155,513 | −$472,484 | −75.24% |
| 2018 | 2018-12-31 | $627,997 | $456,261 | +265.68% |
| 2017 | 2017-12-31 | $171,736 | −$59,868 | −25.85% |
| 2016 | 2016-12-31 | $231,604 | — | — |
Zomedica quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $92,000 | −$45,000 | −32.85% |
| Q1 2026 | 2026-03-31 | $60,000 | −$220,000 | −78.57% |
| Q4 2025 | 2025-12-31 | $107,000 | −$468,000 | −81.39% |
| Q3 2025 | 2025-09-30 | $43,000 | −$1.0M | −96.01% |
| Q2 2025 | 2025-06-30 | $137,000 | −$1.1M | −88.81% |
| Q1 2025 | 2025-03-31 | $280,000 | −$2.1M | −88.01% |
| Q4 2024 | 2024-12-31 | $575,000 | −$1.5M | −71.74% |
| Q3 2024 | 2024-09-30 | $1.1M | −$5.4M | −83.34% |
| Q2 2024 | 2024-06-30 | $1.2M | −$639,000 | −34.30% |
| Q1 2024 | 2024-03-31 | $2.3M | $1.4M | +140.72% |
| Q4 2023 | 2023-12-31 | $2.0M | $1.8M | +897.55% |
| Q3 2023 | 2023-09-30 | $6.5M | $6.0M | +1397.92% |
| Q2 2023 | 2023-06-30 | $1.9M | $1.8M | +2639.71% |
| Q1 2023 | 2023-03-31 | $970,000 | $887,000 | +1068.67% |
| Q4 2022 | 2022-12-31 | $204,000 | $154,000 | +308.00% |
| Q3 2022 | 2022-09-30 | $432,000 | $378,000 | +700.00% |
| Q2 2022 | 2022-06-30 | $68,000 | $40,000 | +142.86% |
| Q1 2022 | 2022-03-31 | $83,000 | $68,000 | +453.33% |
| Q4 2021 | 2021-12-31 | $50,000 | — | — |
| Q3 2021 | 2021-09-30 | $54,000 | $53,387 | +8709.14% |
| Q2 2021 | 2021-06-30 | $28,000 | — | — |
| Q1 2021 | 2021-03-31 | $15,000 | — | — |
| Q3 2020 | 2020-09-30 | $613 | −$80,337 | −99.24% |
| Q4 2019 | 2019-12-31 | $1 | −$22,628 | −100.00% |
| Q3 2019 | 2019-09-30 | $80,950 | −$386,725 | −82.69% |
| Q2 2019 | 2019-06-30 | $5,477 | −$118,997 | −95.60% |
| Q1 2019 | 2019-03-31 | $69,087 | $55,868 | +422.63% |
| Q4 2018 | 2018-12-31 | $22,629 | $15,468 | +216.00% |
| Q3 2018 | 2018-09-30 | $467,675 | $462,900 | +9694.24% |
| Q2 2018 | 2018-06-30 | $124,474 | $122,076 | +5090.74% |
| Q1 2018 | 2018-03-31 | $13,219 | −$144,183 | −91.60% |
| Q4 2017 | 2017-12-31 | $7,161 | — | — |
| Q3 2017 | 2017-09-30 | $4,775 | — | — |
| Q2 2017 | 2017-06-30 | $2,398 | — | — |
| Q1 2017 | 2017-03-31 | $157,402 | — | — |
Zomedica capital expenditures (capex) trends
Over the last five fiscal years, Zomedica's capital expenditures (capex) increased from $14,850 to $567,000, a change of $552,150. The latest reported quarter, Q2 2026, shows $92,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zomedica source filings ↗